Navigation Links
First results from hospital trials testing
Date:10/28/2008

NEW YORK, NY (October 28, 2008) The first stage of the U.S. Department of Defense-funded clinical trials exploring the role of hospital touch surfaces in the transmission of infectious pathogens has been completed and the researchers reported their findings in a poster session at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, D.C. on Tuesday, October 28. The data presented describe the first results of a three phase study where the bioload found on stainless steel, plastic and aluminum objects in intensive care unit rooms were measured. Phases two and three of the study are ongoing. During these phases, the bioload on identical objects made of microbiocidal copper will be measured to determine the effectiveness of copper at combating hospital-acquired infections.

The findings being presented at ICAAC show that the most heavily contaminated objects are those in closest proximity to the patients: bed rails, call buttons and chairs were found to have the highest levels of staphylococcus, methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE). These pathogens can survive for extended periods of time on such objects, which act as reservoirs for the bacteria.

Independent laboratory studies have shown that copper, brass and bronze are more than 99.9 percent effective in killing potentially deadly pathogens, such as MRSA, which are commonly found in healthcare facilities. In response to these findings, the Environmental Protection Agency has registered copper, brass and bronze as antimicrobial materials, allowing public health claims to be made about them.

A similar clinical trial is also being conducted at Selly Oak Hospital, University Hospital Birmingham in the U.K. Results from this trial, also being presented at ICAAC, show a 90-95 percent reduction in contamination on copper alloy surfaces compared to the controls.


'/>"/>

Contact: Geralyn Lederman
glederman@kellencompany.com
212-297-2118
Copper Development Association
Source:Eurekalert

Page: 1

Related biology news :

1. Which came first, the moth or the cactus?
2. First all-African GM crop is resistant to maize streak virus
3. Scientists retrace evolution with first atomic structure of an ancient protein
4. CU-Boulder team discovers first ancient manioc fields in Americas
5. First finding of a metabolite in 1 sex only
6. First orchid fossil puts showy blooms at some 80 million years old
7. First individual genome sequence published
8. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment
9. UNH becomes first university in nation to use landfill gas as primary energy source
10. Scientists in first global study of poison gas in the atmosphere
11. Weight gain between first and second pregnancies associated with increased odds of male second child
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... GARDENS, Fla. , April 11, 2017 /PRNewswire/ ... management and secure authentication solutions, today announced that ... by Intelligence Advanced Research Projects Activity (IARPA) to ... IARPA,s Thor program. "Innovation has been ... and IARPA,s Thor program will allow us to ...
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
Breaking Biology News(10 mins):
(Date:4/27/2017)... ... April 27, 2017 , ... During the ... review how testing for 1,25-Dihydroxyvitamin D can enhance clinical practice. Participants will learn ... 1,25 dihydroxyvitamin D. , Dr. Gregory Plotnikoff, senior consultant with Minnesota Personalized Medicine, ...
(Date:4/27/2017)... , April 27, 2017  Pendant Biosciences, Inc. ... innovative surface modification and drug delivery technologies, today announced ... Innovation, JLABS @ Toronto . ... Officer of Pendant Biosciences, noted, "We are excited to ... community, and are honored to be the ...
(Date:4/26/2017)... ... April 25, 2017 , ... LABS, Inc. (LABS) announced in December ... its extensive test menu: Nucleic Acid Testing (NAT) for ZIKV; and Enzyme Immunoassays (EIAs) ... to offer NAT screening for blood donors under an Investigational New Drug (IND) study ...
(Date:4/25/2017)... ... April 25, 2017 , ... As part of the Stago EdVantage Virtual ... testing for DIC in order to illuminate this clinical problem for people unfamiliar with ... patients resulting in a high degree of morbidity and mortality. DIC is a confusing ...
Breaking Biology Technology: